Company / Revenue
ORTHOPEDIATRICS CORP Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$148.7M
FY2025
5-year range
$71.1M / $148.7M
FY2021-FY2025
Trend
+21.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 3 consecutive years, from $71M in FY2022 to $149M in FY2025.
Based on SEC 10-K filings.
$149M in FY2025 with a 5-year CAGR of +20.9%.
Improved from $98M to $149M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORTHOPEDIATRICS CORP's revenue has grown for 3 consecutive years.
- 5-year CAGR of +20.9%, indicating consistent growth.
- In FY2025, revenue increased 21.6% year-over-year.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $148.7M | +21.6% |
| FY2024 | $122.3M | +24.7% |
| FY2023 | $98.0M | +37.9% |
| FY2022 | $71.1M | -2.0% |
| FY2021 | $72.6M | +26.0% |
| FY2020 | $57.6M | +26.2% |
| FY2019 | $45.6M | +22.3% |
| FY2018 | $37.3M | +20.3% |
| FY2017 | $31.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026